Wuxi Apptec up for two consecutive trading days, Haoyuan Medicine approaching the daily limit, Sunlight No. He, Pharmaron, Pharma Block Sciences, Porton Pharma Solutions, Chempartner Pharmatech, and other stocks rose more than 10%. Southwest Securities research reports pointed out that most CXO leaders' new orders in 2024Q2 achieved double-digit growth compared to the previous quarter. Overseas investment and financing have started to improve since Q3 of 2023, as entering the interest rate reduction cycle, the demand for research and development is rebounding, and CXO overseas orders will further recover.